Remifentanil discontinuation and subsequent intensive care unit-acquired infection: A cohort study

Critical Care

Volumn 13, Issue 2, 2009, Pages

  Nseir, Saad ^a,b   Hoel, Jérémy ^a   Grailles, Guillaume ^a   Soury Lavergne, Aude ^a   Di Pompeo, Christophe ^b   Mathieu, Daniel ^a   Durocher, Alain ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; MIDAZOLAM; NEUROMUSCULAR BLOCKING AGENT; REMIFENTANIL; NARCOTIC ANALGESIC AGENT; PIPERIDINE DERIVATIVE;

ADULT; ARTICLE; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; COHORT ANALYSIS; CONSCIOUSNESS LEVEL; DRUG WITHDRAWAL; FEMALE; HOSPITAL INFECTION; HUMAN; HUMAN CELL; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; RISK FACTOR; SEDATION; TRACHEOSTOMY; UNIVERSITY HOSPITAL; VENTILATOR ASSOCIATED PNEUMONIA; AGED; CROSS INFECTION; FRANCE; MICROBIOLOGY; MIDDLE AGED; OBSERVATION;

ADULT; AGED; ANALGESICS, OPIOID; CROSS INFECTION; FEMALE; FRANCE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; OBSERVATION; PIPERIDINES; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 65549134571     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc7788     Document Type: Article

References (44)

1. Burke JP Infection control - a problem for patient safety N Engl J Med 2003, 348:651-656. 10.1056/NEJMhpr020557 12584377
2. Hugonnet S Chevrolet JC Pittet D The effect of workload on infection risk in critically ill patients Crit Care Med 2007, 35:76-81. 10.1097/ 01.CCM.0000251125.08629.3F 17095946
3. Malacarne P Langer M Nascimben E Moro ML Giudici D Lampati L Bertolini G Building a continuous multicenter infection surveillance system in the intensive care unit: Findings from the initial data set of 9,493 patients from 71 Italian intensive care units Crit Care Med 2008, 36:1105-1113. 10.1097/CCM.0b013e318169ed30 18379234
4. Vincent JL Sakr Y Sprung CL Ranieri VM Reinhart K Gerlach H Moreno R Carlet J Le Gall JR Payen D Sepsis in European intensive care units: results of the SOAP study Crit Care Med 2006, 34:344-353. 10.1097/ 01.CCM.0000194725.48928.3A 16424713
5. Safdar N Abad C Educational interventions for prevention of healthcare-associated infection: A systematic review Crit Care Med 2008, 36:933-940. 10.1097/CCM.0B013E318165FAF3 18431283
6. Nseir S Di Pompeo C Soubrier S Cavestri B Jozefowicz E Saulnier F Durocher A Impact of ventilator-associated pneumonia on outcome in patients with COPD Chest 2005, 128:1650-1656. 10.1378/chest.128.3.1650 16162771
7. Jacobi J Fraser GL Coursin DB Riker RR Fontaine D Wittbrodt ET Chalfin DB Masica MF Bjerke HS Coplin WM Crippen DW Fuchs BD Kelleher RM Marik PE Nasraway SA Jr Murray MJ Peruzzi WT Lumb PD Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult Crit Care Med 2002, 30:119-141. 10.1097/ 00003246-200201000-00020 11902253
8. Muellejans B Matthey T Scholpp J Schill M Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: A randomised, open-label, pharmacoeconomic trial Crit Care 2006, 10:R91. 1550941 16780597 10.1186/cc4939
9. Wilhelm W Kreuer S The place for short-acting opioids: Special emphasis on remifentanil Crit Care 2008, 12(Suppl 3):S5. 2391266 18495056
10. Rahim RT Adler MW Meissler JJ Jr Cowan A Rogers TJ Geller EB Eisenstein TK Abrupt or precipitated withdrawal from morphine induces immunosuppression J Neuroimmunol 2002, 127:88-95. 10.1016/ S0165-5728(02)00103-0 12044979
11. Govitrapong P Suttitum T Kotchabhakdi N Uneklabh T Alterations of immune functions in heroin addicts and heroin withdrawal subjects J Pharmacol Exp Ther 1998, 286:883-889. 9694946
12. Feng P Wilson QM Meissler JJ Jr Adler MW Eisenstein TK Increased sensitivity to Salmonella enterica serovar Typhimurium infection in mice undergoing withdrawal from morphine is associated with suppression of interleukin-12 Infect Immun 2005, 73:7953-7959. 1307081 16299287 10.1128/ IAI.73.12.7953-7959.2005
13. Feng P Truant AL Meissler JJ Jr Gaughan JP Adler MW Eisenstein TK Morphine withdrawal lowers host defense to enteric bacteria: Spontaneous sepsis and increased sensitivity to oral Salmonella enterica serovar Typhimurium infection Infect Immun 2006, 74:5221-5226. 1594820 16926415 10.1128/IAI.00208-06
14. Nseir S Di Pompeo C Diarra M Brisson H Tissier S Boulo M Durocher A Relationship between immunosuppression and intensive care unit-acquired multidrug-resistant bacteria: A case-control study Crit Care Med 2007, 35:1318-1323. 10.1097/01.CCM.0000261885.50604.20 17414081
15. Ramsay MA Savege TM Simpson BR Goodwin R Controlled sedation with alphaxalone-alphadolone BMJ 1974, 2:656-659. 1613102 4835444 10.1136/ bmj.2.5920.656
16. Le Gall JR Lemeshow S Saulnier F A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study JAMA 1993, 270:2957-2963. 8254858 10.1001/jama.270.24.2957
17. Celli BR MacNee W Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper Eur Respir J 2004, 23:932-946. 10.1183/09031936.04.00014304 15219010
18. Korak-Leiter M Likar R Oher M Trampitsch E Ziervogel G Levy JV Freye EC Withdrawal following sufentanil/propofol and sufentanil/midazolam. Sedation in surgical ICU patients: Correlation with central nervous parameters and endogenous opioids Intensive Care Med 2005, 31:380-387. 10.1007/s00134-005-2579-3 15714323
19. Niederman MS Craven D Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia Am J Respir Crit Care Med 2005, 171:388-416. 10.1164/ rccm.200405-644ST 15699079
20. Martin MA Pfaller MA Wenzel RP Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay Ann Intern Med 1989,110:9-16. 2908834
21. Nseir S Favory R Jozefowicz E Decamps F Dewavrin F Brunin G Di Pompeo C Mathieu D Durocher A Antimicrobial treatment for ventilator-associated tracheobronchitis: A randomized, controlled, multicenter study Crit Care 2008, 12:R62. 2481443 18454864 10.1186/cc6890
22. Garner JS Jarvis WR Emori TG Horan TC Hughes JM CDC definitions for nosocomial infections, 1988 Am J Infect Control 1988, 16:128-140. 10.1016/0196-6553(88)90053-3 2841893
23. Kooi van der TI de Boer AS Mannien J Wille JC Beaumont MT Mooi BW van den HS Incidence and risk factors of device-associated infections and associated mortality at the intensive care in the Dutch surveillance system Intensive Care Med 2007, 33:271-278. 10.1007/s00134-006-0464-3 17146632
24. Koh DB Gowardman JR Rickard CM Robertson IK Brown A Prospective study of peripheral arterial catheter infection and comparison with concurrently sited central venous catheters Crit Care Med 2008, 36:397-402. 10.1097/ CCM.0b013e318161f74b 18216598
25. Alp E Guven M Yildiz O Aygen B Voss A Doganay M Incidence, risk factors and mortality of nosocomial pneumonia in intensive care units: A prospective study Ann Clin Microbiol Antimicrob 2004, 3:17. 521500 15369593 10.1186/1476-0711-3-17
26. Apostolopoulou E Bakakos P Katostaras T Gregorakos L Incidence and risk factors for ventilator-associated pneumonia in 4 multidisciplinary intensive care units in Athens, Greece Respir Care 2003, 48:681-688. 12841859
27. Weinert CR Kethireddy S Roy S Opioids and Infections in the Intensive Care Unit Should Clinicians and Patients be Concerned? J Neuroimmune Pharmacol 2008, 3:218-229. 10.1007/s11481-008-9124-4 18773298
28. Craven DE Preventing ventilator-associated pneumonia in adults: Sowing seeds of change Chest 2006, 130:251-260. 10.1378/chest.130.1.251 16840410
29. Acquarolo A Urli T Perone G Giannotti C Candiani A Latronico N Antibiotic prophylaxis of early onset pneumonia in critically ill comatose patients. A randomized study Intensive Care Med 2005, 31:510-516. 10.1007/s00134-005-2585-5 15754197
30. Sirvent JM Torres A El Ebiary M Castro P de Batlle J Bonet A Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma Am J Respir Crit Care Med 1997, 155:1729-1734. 9154884
31. Nseir S Di Pompeo C Jozefowicz E Cavestri B Brisson H Nyunga M Soubrier S Durocher A Relationship between tracheotomy and ventilator-associated pneumonia: A case control study Eur Respir J 2007, 30:314-320. 10.1183/ 09031936.06.00024906 16870667
32. Nseir S Di Pompeo C Brisson H Dewavrin F Tissier S Diarra M Boulo M Durocher A Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome Crit Care 2006, 10:R143. 1751051 17026755 10.1186/cc5063
33. Feng P Meissler JJ Jr Adler MW Eisenstein TK Morphine withdrawal sensitizes mice to lipopolysaccharide: Elevated TNF-alpha and nitric oxide with decreased IL-12 J Neuroimmunol 2005, 164:57-65. 10.1016/ j.jneuroim.2005.03.017 15913793
34. West JP Dykstra LA Lysle DT Immunomodulatory effects of morphine withdrawal in the rat are time dependent and reversible by clonidine Psychopharmacology (Berl) 1999, 146:320-327. 10.1007/s002130051123 10541733
35. Avila AH Alonzo NC Bayer BM Immune cell activity during the initial stages of withdrawal from chronic exposure to cocaine or morphine J Neuroimmunol 2004, 147:109-113. 10.1016/j.jneuroim.2003.10.023 14741439
36. Spies CD von DV Eggers V Jetschmann G El Hilali R Egert J Fischer M Schroder T Hoflich C Sinha P Paschen C Mirsalim P Brunsch R Hopf J Marks C Wernecke KD Pragst F Ehrenreich H Muller C Tonnesen H Oelkers W Rohde W Stein C Kox WJ Altered cell-mediated immunity and increased postoperative infection rate in long-term alcoholic patients Anesthesiology 2004, 100:1088-1100. 10.1097/00000542-200405000-00010 15114205
37. Spies C Eggers V Szabo G Lau A Von DV Schoenfeld H Althoff H Hegenscheid K Bohm B Schroeder T Pfeiffer S Ziemer S Paschen C Klein M Marks C Miller P Sander M Wernecke KD Achterberg E Kaisers U Volk HD Intervention at the level of the neuroendocrine-immune axis and postoperative pneumonia rate in long-term alcoholics Am J Respir Crit Care Med 2006, 174:408-414. 10.1164/rccm.200506-907OC 16728716
38. Tiong GK Pierce TL Olley JE Sub-chronic exposure to opiates in the rat: effects on brain levels of substance P and calcitonin gene-related peptide during dependence and withdrawal J Neurosci Res 1992, 32:569-575. 10.1002/jnr.490320412 1382137
39. Wang X Douglas SD Peng JS Zhou DJ Wan Q Ho WZ An in vitro model of morphine withdrawal manifests the enhancing effect on human immunodeficiency virus infection of human T lymphocytes through the induction of substance P Am J Pathol 2006, 169:1663-1670. 1780221 17071590 10.2353/ajpath.2006.060358
40. REA-RAISIN 2005: Surveillance of ICU-aquired infections in adult critically ill patients in France http://www.invs.sante.fr
41. de Wit M Gennings C Jenvey WI Epstein SK Randomized trial comparing daily interruption of sedation and nursing-implemented sedation algorithm in medical intensive care unit patients Crit Care 2008, 12:R70. 2481461 18492267 10.1186/cc6908
42. Tanios MA de Wit M Epstein SK Devlin JW Perceived barriers to the use of sedation protocols and daily sedation interruption: A multidisciplinary survey J Crit Care 2009, 24:66-73. 10.1016/j.jcrc.2008.03.037 19272541
43. Payen JF Chanques G Mantz J Hercule C Auriant I Leguillou JL Binhas M Genty C Rolland C Bosson JL Current practices in sedation and analgesia for mechanically ventilated critically ill patients: A prospective multicenter patient-based study Anesthesiology 2007, 106:687-695. 10.1097/01.anes.0000264747.09017.da 17413906
44. Kwak S Chung S Li M Bae H Remifentanil attenuates LPS-induced neutrophil activation Crit Care Med 2008, 35:A60. (abstract)